PADI4 and serum lipopolysaccharide activity: The application of pan-PAD inhibitors, which inhibit the activity of both PAD2 and PAD4, can remarkably improve the survival in mouse models of LPS-induced endotoxemia and cecal ligation and puncture (CLP)-induced sepsis (100–102).